Marina Wolfson - Apr 14, 2025 Form 4 Insider Report for BiomX Inc. (PHGE)

Role
Chief Financial Officer
Signature
/s/ Marina Wolfson
Stock symbol
PHGE
Transactions as of
Apr 14, 2025
Transactions value $
$0
Form type
4
Date filed
4/18/2025, 04:01 PM
Previous filing
Jul 15, 2024
SEC
View on sec.gov
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHGE Common Stock Award $0 +68.5K $0.00 68.5K Apr 14, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHGE Common Stock Options - right to Buy Award $0 -95K -50% $0.00 95K Apr 14, 2025 Common Stock 95K $0.54 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of 68,545 Restricted Stock Units ("RSUs"). The RSUs are immediately vested and convert into the Issuer's shares of common stock on a one-for-one basis.
F2 The options vest and become exercisable over four years, with 25% of the shares of common stock subject to the option vesting on April 14, 2026, and the reminder vesting in 12 equal quarterly installments over three years.